An Inhibitor of Arachidonate 5-Lipoxygenase, Nordy, Induces Differentiation and Inhibits Self-Renewal of Glioma Stem-Like Cells

Stem Cell Reviews and Reports

Volumn 7, Issue 2, 2011, Pages 458-470

  Wang, Bin ^a   Yu, Shi cang ^a   Jiang, Jian yong ^a   Porter, Gavin Wallace ^b   Zhao, Lin tao ^a   Wang, Zhe ^a   Tan, Hong ^a   Cui, You hong ^a   Qian, Cheng ^a   Ping, Yi fang ^a   Bian, Xiu wu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Memorial Sloan Kettering ^*  (United States)

Author keywords

Cancer stem cells; Cell differentiation; Glioma; Lipoxygenase inhibitor; Nordihydroguaiaretic acid

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD133 ANTIGEN; DRUG DERIVATIVE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN; HOMEODOMAIN PROTEIN; INTERMEDIATE FILAMENT PROTEIN; KI 67 ANTIGEN; LEUKOCYTE ANTIGEN; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR; MELK PROTEIN, HUMAN; NANOG PROTEIN, HUMAN; NERVE PROTEIN; NESTIN; NORDIHYDROGUAIARETIC ACID; NORDY; OCTAMER TRANSCRIPTION FACTOR 4; PEPTIDE; POU5F1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL; ARTICLE; ASTROCYTE; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; ENZYMOLOGY; FEMALE; GLIOMA; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTIGENS, CD; ARACHIDONATE 5-LIPOXYGENASE; ASTROCYTES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KI-67 ANTIGEN; LEUKOTRIENE B4; LIPOXYGENASE INHIBITORS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; NORDIHYDROGUAIARETIC ACID; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; PROTEIN-SERINE-THREONINE KINASES; SOXB1 TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

ALOX;

EID: 79955015036     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9175-9     Document Type: Article

References (45)

1. Visvader, J. E., & Lindeman, G. J. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8, 755-68.
2. Clarke, M. F., Dick, J. E., Dirks, P. B., et al. (2006). Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res, 66, 9339-44.
3. Lee, J., Son, M. J., Woolard, K., et al. (2008). Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell, 13, 69-80.
4. Wang, J., Sakariassen, P. O., Tsinkalovsky, O., et al. (2008). CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer, 122, 761-8.
5. Beier, D., Hau, P., Proescholdt, M., et al. (2007). CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res, 67, 4010-5.
6. Chen, J. H., Bian, X. W., Yao, X. H., et al. (2006). Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells. Biochem Biophys Res Commun, 342, 1368-74.
7. Bian, X. W., Xu, J. P., Ping, Y. F., et al. (2008). Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells. Proteomics, 8, 484-94.
8. Chen, Y., Hu, Y., Zhang, H., Peng, C., & Li, S. (2009). Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet, 41, 783-92.
9. Singh, S. K., Clarke, I. D., Terasaki, M., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res, 63, 5821-8.
10. Bao, S. D., Wu, Q. L., Sathornsumetee, S., et al. (2006). Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res, 66, 7843-8.
11. Yu, S. C., Ping, Y. F., Yi, L., et al. (2008). Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett, 265, 124-34.
12. Yi, L., Zhou, Z. H., Ping, Y. F., et al. (2007). Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma. Mod Pathol, 20, 1061-8.
13. Nathoo, N., Prayson, R. A., Bondar, J., et al. (2006). Increased expression of 5-lipoxygenase in high-grade astrocytomas. Neurosurgery, 58, 347-54.
14. Lim JY, Oh JH, Jung JR, et al. MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells. J Neurooncol 2009.
15. Ishii, K., Zaitsu, M., Yonemitsu, N., Kan, Y., Hamasaki, Y., & Matsuo, M. (2009). 5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines. Clin Neuropathol, 28, 445-52.
16. Zhang, L., Zhang, W. P., Hu, H., et al. (2006). Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma. Neuropathology, 26, 99-106.
17. Rajaraman, P., Brenner, A. V., Butler, M. A., et al. (2009). Common variation in genes related to innate immunity and risk of adult glioma. Cancer Epidemiol Biomark Prev, 18, 1651-8.
18. Aguado, T., Carracedo, A., Julien, B., et al. (2007). Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J Biol Chem, 282, 6854-62.
19. Ben-Porath, I., Thomson, M. W., Carey, V. J., et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet, 40, 499-507.
20. Somervaille, T. C. P., Matheny, C. J., Spencer, G. J., et al. (2009). Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell, 4, 129-40.
21. Wong, D. J., Liu, H., Ridky, T. W., Cassarino, D., Segal, E., & Chang, H. Y. (2008). Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell, 2, 333-44.
22. Ito, K., Bernardi, R., Morotti, A., et al. (2008). PML targeting eradicates quiescent leukaemia-initiating cells. Nature, 453, 1072-8.
23. Furstenberger, G., Krieg, P., Muller-Decker, K., & Habenicht, A. J. (2006). What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer, 119, 2247-54.
24. Hyde, C. A., & Missailidis, S. (2009). Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int Immunopharmacol, 9, 701-15.
25. Peters-Golden, M., & Henderson, W. R., Jr. (2007). Leukotrienes. N Engl J Med, 357, 1841-54.
26. Pidgeon, G. P., Lysaght, J., Krishnamoorthy, S., et al. (2007). Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev, 26, 503-24.
27. Öhd, J. F., Nielsen, C. K., Campbell, J., Landberg, G., Löfberg, H., & Sjölander, A. (2003). Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology, 124, 57-70.
28. Sun, Z., Sood, S., Li, N., et al. (2006). Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7, 12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors. Carcinogenesis, 27, 1902-8.
29. Melstrom, L. G., Bentrem, D. J., Salabat, M. R., et al. (2008). Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res, 14, 6525-30.
30. Cianchi, F., Cortesini, C., Magnelli, L., et al. (2006). Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells. Mol Cancer Ther, 5, 2716-26.
31. Hammamieh, R., Sumaida, D., Zhang, X., Das, R., & Jett, M. (2007). Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism. BMC Cancer, 7, 138.
32. Kang, M. K., & Kang, S. K. (2007). Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev, 16, 837-47.
33. Chen, Y. C., Hsu, H. S., Chen, Y. W., et al. (2008). Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE, 3, e2637.
34. Gangemi, R. M., Griffero, F., Marubbi, D., et al. (2009). SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells, 27, 40-8.
35. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-76.
36. Dincbas-Renqvist, V., Pepin, G., Rakonjac, M., et al. (2009). Human Dicer C-terminus functions as a 5-lipoxygenase binding domain. Biochim Biophys Acta, 1789, 99-108.
37. Godlewski, J., Nowicki, M. O., Bronisz, A., et al. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res, 68, 9125-30.
38. Wellner, U., Schubert, J., Burk, U. C., et al. (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol, 11, 1487-95.
39. Viswanathan, S. R., Powers, J. T., Einhorn, W., et al. (2009). Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet, 41, 843-8.
40. Hambardzumyan, D., Becher, O. J., Rosenblum, M. K., Pandolfi, P. P., Manova-Todorova, K., & Holland, E. C. (2008). PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev, 22, 436-48.
41. Bao, S., Wu, Q., McLendon, R. E., et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-60.
42. Bleau, A. M., Hambardzumyan, D., Ozawa, T., et al. (2009). PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell, 4, 226-35.
43. Sell, S. (2006). Cancer stem cells and differentiation therapy. Tumour Biol, 27, 59-70.
44. Massard, C., Deutsch, E., & Soria, J. C. (2006). Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol, 17, 1620-4.
45. Gupta, P. B., Onder, T. T., Jiang, G., et al. (2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 138, 645-59.